发明名称
摘要 PROBLEM TO BE SOLVED: To obtain the subject medicine having an excellent antagonic effect against Substance P and Neurokinin A and good oral absorption by including a saturated heterocyclic compound as an active ingredient. SOLUTION: This medicine, which can be used to prevent tachykinin-mediated diseases, is obtained by including a compound shown by the formula [R<1> and R<2> are each an aryl, a heteroaryl, etc.; A is methylene, carbonyl, etc.; B is a single bond, a 1-4C alkylene, etc.; D is O or S; E is a (substituted) 1-6C alkylene, a 3-8C alkylene; G is a 1-4C alkylene; a 2-4C alkenylene; L is N(R<3> ); R<3> is an aryl, a heteroaryl, etc.], as an active ingredient. The medicine is an inhibitor, for example, to NK1 receptor and/or NK2 receptor in order to treat diseases such as asthma, bronchitis, rhinitis, allergy, and involuntary micturition. It is preferable to administer the medicine, for example, in a dose of 0.1-' 50 mg/kg once to several times per day orally.
申请公布号 JP3192631(B2) 申请公布日期 2001.07.30
申请号 JP19980169667 申请日期 1998.05.27
申请人 发明人
分类号 C07D277/04;A61K31/42;A61K31/421;A61K31/423;A61K31/425;A61K31/426;A61K31/445;A61K31/495;A61K31/496;A61K31/535;A61K31/5375;A61K31/5377;A61K31/54;A61K31/55;A61P11/00;A61P13/02;A61P15/00;A61P25/00;A61P29/00;A61P37/08;A61P43/00;C07D263/06;C07D263/52;C07D263/56;C07D265/30;C07D267/08;C07D413/06;C07D413/12;C07D413/14;C07D417/12;C07D471/10;C07D491/10;C07D495/10;C07D498/10;C07D521/00;(IPC1-7):A61K31/535;C07M7:00 主分类号 C07D277/04
代理机构 代理人
主权项
地址